Eukaryotic Versus Prokaryotic Cell-Free Systems for Complex Proteins
Protein complexity, not cost, determines which cell-free system to choose.
Priya Venkataraman
Priya Venkataraman
12 stories
Cost of Protein Expression Failure Across R&D Project Stages
Expression costs depend on which R&D stage fails to produce protein.
Priya Venkataraman
Platform Standardization Decisions for Protein Expression in R&D Labs
Labs must weigh cell-based and cell-free systems against protein needs, throughput, reproducibility.
Priya Venkataraman
When CFPS Is Not the Right Expression Platform
Complex proteins and large-scale production often demand cell-based systems instead.
Priya Venkataraman
Viral Antigen Protein Production for Research Reagents Using CFPS
Cell-free synthesis accelerates viral antigen production for research without living cells.
Priya Venkataraman
Insoluble Protein Solubility Tagging and Refolding in CFPS
Priya Venkataraman
Membrane Protein Expression Failures in Cell-Based Systems
Researchers can now diagnose why membrane proteins fail to express and know when to abandon cells.
Priya Venkataraman
Isotopic Labeling of Proteins Using Cell-Free Synthesis for NMR
Cell-free protein synthesis achieves isotopic labeling precision that living cells cannot.
Priya Venkataraman
SPR and Biophysical Assay Protein Preparation Using CFPS
Cell-free protein synthesis enables direct SPR analysis of difficult-to-express proteins.
Priya Venkataraman
Lot-Level QC Data Standards in CFPS Reagent Supply
Meaningful lot-level QC must measure function, not just identity, to guarantee CFPS performance.
Priya Venkataraman
Linear DNA Templates Versus Plasmid in High-Throughput CFPS Screens
Linear templates cut screening timelines from days to hours by skipping plasmid preparation.
Priya Venkataraman
Cost-per-Reaction Breakdown for Commercial CFPS Kits
Four variables determine the true cost of each CFPS reaction, not just list price.
Priya Venkataraman